
Tilray Brands, Inc.
TLRYNASDAQHealthcareDrug Manufacturers - Specialty & Generic
Previous close
$4.84
+$0.17 · +3.64%
TLRY company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
62
Undervalued
Momentum
20
Strong Down
Sentiment
33
Bearish
Risk resilience
36
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteTilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Headquarters
- CA
- CEO
- Irwin David Simon
- Listed since
- Jul 19, 2018
- Employees
- 3,595
Market position
Day range
Current $4.84
52-week range
Current $4.84
- Open
- $4.72
- Previous close
- $4.67
- Volume
- 4.25M
- 0.88× average
- Average volume
- 4.85M
- Average daily volume
- Market cap
- 541.27M USD
- Beta
- 1.91
- Market reference 1
- 50-day average
- $4.496
- +7.65% above average
- 200-day average
- $7.0039
- -30.90% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 786.38M USD
- EV / EBITDA
- -20.39×
- Earnings yield
- -19.96%
- Free cash flow yield
- -16.63%
Profitability & efficiency
- Return on equity
- -7.59%
- Return on assets
- -5.26%
- Return on invested capital
- -3.14%
Financial health
- Current ratio
- 2.21×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 915.45M USD | 1.13B USD | 1.07B USD | 844.72M USD | 628.37M USD |
| Cost of goods sold | 655.01M USD | 796.88M USD | 770.66M USD | 646.77M USD | 511.56M USD |
| Gross profit | 260.44M USD | 330.11M USD | 304.33M USD | 197.95M USD | 116.82M USD |
| Research and development | 361K USD | 389.7K USD | 865.23K USD | 918.64K USD | 1.52M USD |
| Selling, general, and administrative | 295.25M USD | 356.06M USD | 341.63M USD | 311.13M USD | 233.38M USD |
| Operating expenses | 323.47M USD | 3.46B USD | 542.43M USD | 2.04B USD | 350.08M USD |
| Interest income | 6.25M USD | 15.61M USD | 17.48M USD | 44.48M USD | 11.74M USD |
| Interest expense | 29.91M USD | 56.71M USD | 67.13M USD | 62.79M USD | 39.68M USD |
| Depreciation and amortization | 19.59M USD | 183.17M USD | 172.93M USD | 175.31M USD | 154.59M USD |
| Operating income | −63.03M USD | −3.13B USD | −238.1M USD | −1.84B USD | −233.27M USD |
| Net income | −122.57M USD | −3B USD | −333.8M USD | −1.96B USD | −476.8M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 18%
- 2 beats, 9 misses, 0 met estimates
- Average EPS surprise
- -759.24%
- 11 comparable reports
- Latest EPS result
- -0.43
- Estimate -0.01 · Miss by 3471.43%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$65.01
1243.18% upsidePrice history unavailable
High $190Average $65.01Low $10.00Rating distribution
20 ratingsTLRY news
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Dec 2, 2025 | 1:10 | — | — |
Stock split | May 3, 2021 | 8,381:10,000 | — | — |
Effective Dec 2, 2025
1:10
Effective May 3, 2021
8,381:10,000
TLRY peers
ETFs holding TLRY
Funds reporting this stock among their holdings, ordered by reported position size.
Amplify Alternative Harvest ETFMJ13.73M11.58%118.56M USD1.12%$26.35+1.62%
Vanguard Health Care ETFVHT1.6M0.01%20.9B USD0.09%$327.7+1.24%
SoFi Social 50 ETFSFYF679.97K1.65%40.01M USD0.29%$63.315+1.50%
AdvisorShares Pure Cannabis ETFYOLO538.51K1.48%36.39M USD0.91%$3.06+3.03%
iShares U.S. Small-Cap Equity Factor ETFSMLF391.53K0.01%4.3B USD0.15%$89.29+0.80%
Dimensional - International Small Cap ETFDFIS369.47K0.01%5.91B USD0.39%$37.545+0.71%
Dimensional - International Core Equity Market ETFDFAI338.4K0.00%18.23B USD0.18%$43.35+0.81%
Fidelity MSCI Health Care Index ETFFHLC269.67K0.01%3.29B USD0.08%$84.66+1.22%
Amplify Alternative Harvest ETFMJ- Market value
- 13.73M
- Weight
- 11.58%
- AUM
- 118.56M USD
- Expense ratio
- 1.12%
- Price / 1D
- $26.35+1.62%
Vanguard Health Care ETFVHT- Market value
- 1.6M
- Weight
- 0.01%
- AUM
- 20.9B USD
- Expense ratio
- 0.09%
- Price / 1D
- $327.7+1.24%
SoFi Social 50 ETFSFYF- Market value
- 679.97K
- Weight
- 1.65%
- AUM
- 40.01M USD
- Expense ratio
- 0.29%
- Price / 1D
- $63.315+1.50%
AdvisorShares Pure Cannabis ETFYOLO- Market value
- 538.51K
- Weight
- 1.48%
- AUM
- 36.39M USD
- Expense ratio
- 0.91%
- Price / 1D
- $3.06+3.03%
iShares U.S. Small-Cap Equity Factor ETFSMLF- Market value
- 391.53K
- Weight
- 0.01%
- AUM
- 4.3B USD
- Expense ratio
- 0.15%
- Price / 1D
- $89.29+0.80%
Dimensional - International Small Cap ETFDFIS- Market value
- 369.47K
- Weight
- 0.01%
- AUM
- 5.91B USD
- Expense ratio
- 0.39%
- Price / 1D
- $37.545+0.71%
Dimensional - International Core Equity Market ETFDFAI- Market value
- 338.4K
- Weight
- 0.00%
- AUM
- 18.23B USD
- Expense ratio
- 0.18%
- Price / 1D
- $43.35+0.81%
Fidelity MSCI Health Care Index ETFFHLC- Market value
- 269.67K
- Weight
- 0.01%
- AUM
- 3.29B USD
- Expense ratio
- 0.08%
- Price / 1D
- $84.66+1.22%
Continue in GoAI
Research TLRYresearch.disclaimer











